A characterization and targeting of the infarct border zone in a swine model of myocardial infarction.


INTRODUCTION Novel therapies for myocardial infarction (MI) involving stem cells, gene therapy, biomaterials, or revascularization strategies have shown promise in animal studies and clinical trials, but results have been limited partially due to the injection of therapeutics into ischemic myocardium that cannot support their mechanism of action. Accurate… (More)
DOI: 10.1111/j.1752-8062.2012.00432.x


  • Presentations referencing similar topics